Pharmaceutical

KGYY-15 by Op-T-Mune for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval

KGYY-15 is under clinical development by Op-T-Mune and currently in Phase I for Type 1 Diabetes (Juvenile Diabetes).

Dec 27, 2024 - 06:00
KGYY-15 is under clinical development by Op-T-Mune and currently in Phase I for Type 1 Diabetes (Juvenile Diabetes).
Read the original article

Tags:

Previous Article

Lidocaine by MEDRx for Postherpetic Neuralgia: Likelihood of Approval

Next Article

Tricaprilin by Cerecin for Infantile Spasm (West Syndrome): Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA panel votes in favor of the first over-the-counter birth control pill

FDA panel votes in favor of the first over-the-counter ...

May 11, 2023

Opinion: Fear-based messaging doesn’t stop drug use. But it does make things worse

Opinion: Fear-based messaging doesn’t stop drug use. Bu...

May 11, 2023

M&A in pharmaceutical in Italy increased in Q2 2023

Jul 31, 2023